Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 7.1B | 7.6B | 7.0B | 7.2B |
Cost of revenue | 3.2B | 3.4B | 3.1B | 3.2B |
Gross profit | 3.9B | 4.2B | 3.8B | 4.0B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 2.8B | 2.9B | 2.7B | 2.7B |
Operating income | 212.6M | 338.3M | 239.3M | 338.2M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 297.5M | 275.2M | 271.1M | 272.5M |
Other income expense | — | — | — | — |
Pretax income | 6.1M | 168.2M | -61.2M | 118.3M |
Tax provision | -14.2M | 40.9M | 1.2M | 36.5M |
Net income | 20.2M | 127.3M | -62.4M | 81.9M |
Basic EPS | — | 0.4 | -0.1 | 0.3 |
Diluted EPS | — | 0.4 | -0.1 | 0.3 |
Basic average shares | — | 323.9M | 303.7M | 317.7M |
Diluted average shares | — | 323.9M | 303.7M | 322.5M |
EBITDA | 1.2B | 1.4B | 1.2B | 1.3B |
Net income from continuing op. | — | — | — | — |
Minority interests | -2.3M | -7.5M | 32.0M | 3.3M |
Preferred stock dividends | 0 | 0 | 0 | 0 |